Neuvé MD
Get started

Semaglutide vs Tirzepatide: Which GLP-1 Fits You?

Both quiet appetite and slow digestion. Tirzepatide adds a second receptor and tends to produce more average weight loss in trials; semaglutide is often the gentler, lower-cost starting point. Here’s how they actually compare — and how a licensed clinician decides what fits you.

Take the free 3-minute quiz Jump to the comparison

No card required · Clinician-reviewed

Reviewed for a general audience. Not medical advice — all prescribing decisions are made by a U.S.-licensed clinician after intake.

The short answer

  • Lean tirzepatide if you want the higher average trial weight-loss range, have a higher starting BMI, or have plateaued on semaglutide — if a clinician agrees it’s medically appropriate.
  • Lean semaglutide if this is your first GLP-1, you’re sensitive to nausea, or you want the lower monthly starting price.
  • Either way, start low. Most side effects come from moving up too fast — not from the medication itself.

Not sure yet? The quiz organizes your goals and history so a clinician can review what’s medically appropriate.

Take the free 3-minute quiz

Side-by-side comparison

How it works
Semaglutide: GLP-1 receptor agonist (single)
Tirzepatide: GIP + GLP-1 receptor agonist (dual)
Typical weight loss in trials*
Semaglutide: ~15% body weight over ~68 weeks (STEP 1)
Tirzepatide: ~20–22% body weight over ~72 weeks at higher doses (SURMOUNT-1)
Dosing formats (via Neuvé when prescribed)
Semaglutide: Weekly injection or daily oral RDT
Tirzepatide: Weekly injection or daily oral RDT
Appetite suppression
Semaglutide: Strong
Tirzepatide: Often strongest
GI side effects
Semaglutide: Common early; often milder
Tirzepatide: Common early; can be more pronounced
Metabolic notes
Semaglutide: Improves glycemic markers in trials
Tirzepatide: Improves; added GIP effect in trials
Monthly starting prices through Neuvé†
Semaglutide: From $179/month
Tirzepatide: From $240/month
Common starting point
Semaglutide: First-time GLP-1; cost-sensitive
Tirzepatide: Higher BMI; plateau on semaglutide

*Population averages from published trials (e.g., STEP 1 for semaglutide; SURMOUNT-1 for tirzepatide). Not a head-to-head comparison. Individual results vary; your response depends on dose, adherence, lifestyle, and clinical factors.

†Prices are starting-at estimates. Medication when approved, clinician consult and review, shipping, and injectable supplies are included. Labs are separate when required. Confirm current tiers on the weight loss program page.

How semaglutide works

Semaglutide mimics GLP-1, a gut hormone released after eating. It slows how quickly your stomach empties, signals fullness to the brain, and blunts the “food noise” that drives snacking between meals.

Appetite changes often show up within the first couple of weeks for many people. Meaningful weight change, when it happens, more often unfolds over the first few months — not overnight.

Because it acts on a single receptor, semaglutide is often the gentler introduction to this class of medication and the more affordable path when a clinician decides it’s appropriate.

How tirzepatide works

Tirzepatide activates both GLP-1 and GIP receptors. The added GIP activity is linked, in trials, to stronger average appetite suppression and greater average weight loss in its own trial program than was seen with semaglutide in separate studies. These were not head-to-head trials, so they do not prove tirzepatide is better for any one person. Individual results vary; a clinician decides what fits you.

The trade-off is potency: GI side effects can be more noticeable for some people. Clinicians usually start low and titrate slowly so your body can adapt.

Injectable vs oral RDT (same molecule, different format)

Through Neuvé, when a clinician prescribes, both semaglutide and tirzepatide may be available as:

Weekly injection

The usual on-ramp for new patients, often starting at a microdose.

Daily oral rapid-dissolve tablet (RDT)

For people who prefer not to inject, when clinically appropriate.

The format decision is practical and clinical: needle comfort, how you stick to routines, clinician judgment, and cost tier. Microdose injectable is the common starting point for people new to GLP-1 care.

Format availability can vary by clinical eligibility and state. Your assessment confirms what is available to you.

Medications, in plain language

Brand-name pens vs clinician-prescribed compounded options

People searching “Ozempic,” “Wegovy,” “Mounjaro,” or “Zepbound” are often comparing brand-name pens with clinician-prescribed compounded formulations prepared by state-licensed U.S. fulfillment facilities when a clinician writes a prescription.

Brand-name products

FDA-approved medications sold under those brand names. Their labeling, manufacturing pathway, and regulatory status are specific to those products.

Compounded formulations

Prepared by licensed fulfillment facilities when prescribed. Their regulatory pathway differs from FDA-approved branded products. Compounded formulations are not FDA-approved as finished brand products. They are not the same as, and should not be described as equivalent to, brand-name pens.

Why people choose cash-pay telehealth

Access, continuity of titration, transparent monthly pricing, and a clinician who adjusts the plan — not a one-shipment clinic.

Neuvé’s role: a U.S.-licensed clinician evaluates your history (and labs when clinically appropriate). Medication is prescribed only if medically appropriate, then shipped discreetly when approved. Payment does not guarantee eligibility, a prescription, or any outcome.

Side effects to expect (and when to seek care)

Semaglutide and tirzepatide share a side-effect profile. Most effects are dose-related, show up in the early weeks, and often settle as your body adjusts — especially when titration is slow.

Nausea

Smaller meals, slower eating.

Constipation

Fluids, fiber, movement.

Reflux or burping

Often eases after a dose increase settles.

Fatigue

Sometimes from under-eating — protein matters.

Injection-site redness

Mild; usually fades within a day or two.

Muscle-loss risk

Protein intake and resistance training, as general education.

Seek care promptly for severe abdominal pain, persistent vomiting, or signs of an allergic reaction. If you are having a medical emergency, call 911.

Who may not be a candidate (high-level): These medicines are not for use during pregnancy. If you become pregnant, contact your clinician and stop treatment as directed. If you are planning pregnancy, ask your clinician about timing (some labels advise stopping well before trying to conceive). If you are breastfeeding, discuss risks and benefits with your clinician before use — this is educational, not a diagnosis tool. Personal or family history of medullary thyroid carcinoma (MTC) or MEN2 are common label contraindications; a U.S.-licensed clinician decides eligibility after intake.

Cost comparison through Neuvé

Both medications are available as a weekly injection or a daily oral RDT when prescribed. Microdosing is the usual starting point for new patients.

Semaglutide

  • Weekly injection · microdose$179/month
  • Weekly injection · standard dose$219/month
  • Daily oral RDT$329/month

Tirzepatide

  • Weekly injection · microdose$240/month
  • Weekly injection · standard dose$349/month
  • Daily oral RDT$279/month
What those numbers mean (and don’t)
  • Medication when approved, clinician consult and review, shipping, and injectable supplies are included
  • Lab testing is charged separately when required; pricing is confirmed before any charge
  • Cash-pay only — not billed to insurance
  • Payment does not guarantee eligibility, prescription, or any outcome
  • Cancel anytime from the member dashboard

See which protocol and format a clinician is most likely to start you on.

Take the free 3-minute quiz GLP-1 Weight Loss pricing

What the first month usually feels like

This is expectation-setting, not a prediction of your timeline. Individual results vary.

Weeks 1–2

Appetite change for many people; GI adjustment is common as your body meets the medication.

Weeks 3–4

Titration decisions start to matter. Message your care team if side effects linger or feel hard to manage.

Month 2+

Weight change becomes more noticeable for many; the plan adapts to your data — not the calendar.

What sets clinician-led care apart: ongoing titration, messaging support, labs when clinically appropriate, and dashboard tracking so follow-up isn’t a cold restart every month.

How Neuvé starts GLP-1 care

Most clinics stop at the shipment. Neuvé is built as a continuous loop — quiz, clinician review, protocol, shipping, and tracked progress.

  1. 13-minute eligibility quizGoals, history, context. Free. No card required.
  2. 2Clinician reviewA U.S.-licensed clinician reviews your chart (often within 24–48 hours). Labs only if clinically indicated. Video visit only if required.
  3. 3Protocol writtenIf medically appropriate: medication + titration plan, sent to a state-licensed U.S. fulfillment facility.
  4. 4Shipped & supportedDiscreet, climate-controlled delivery; messaging support as you titrate.
  5. 5Progress trackedWeight, labs when ordered, and follow-up live in your dashboard. The plan adapts with you — not a one-shipment clinic.

Available options are confirmed by your assessment and state eligibility. Prescriptions are never guaranteed.

Take the free 3-minute quiz How it works

Switching between semaglutide and tirzepatide

Switching is common when weight loss stalls or side effects are hard to tolerate. Under clinician guidance, the usual approach is to restart at an appropriate introductory dose — not a one-to-one dose match from your previous medication.

That decision is clinical, not DIY. Do not change medications or doses on your own.

Questions, answered.

Is tirzepatide better than semaglutide for weight loss?

In published trial programs, tirzepatide has produced greater average weight loss than semaglutide at comparable study durations — reflecting its dual GIP + GLP-1 action. That said, “better” depends on your medical history, how you tolerate GI effects, and your budget. Many people reach their goals on semaglutide with fewer GI effects and a lower monthly starting price. Individual results vary; a clinician decides what’s medically appropriate for you.

What is the difference between semaglutide and tirzepatide?

Semaglutide is a single agonist — it mimics GLP-1 to slow gastric emptying and reduce appetite. Tirzepatide is a dual agonist — it activates both GIP and GLP-1 receptors, which in its own trial program was associated with stronger average appetite suppression and greater average weight loss than was seen with semaglutide in separate studies — not a head-to-head comparison.

Can you switch from semaglutide to tirzepatide?

Yes, under clinician guidance. Switching is common when progress stalls or side effects are hard to tolerate. Your clinician typically restarts at an introductory dose rather than matching your previous dose one-to-one. Do not self-switch.

Which one has more side effects?

Both share the same general profile — nausea, constipation, reflux, and fatigue are the most common early effects, and many fade as titration settles. Because tirzepatide is often more potent, GI effects can feel more pronounced at comparable stages — which is why most new patients begin at a microdose.

How much do semaglutide and tirzepatide cost per month through Neuvé?

Through Neuvé MD, semaglutide programs start at $179/month and tirzepatide programs start at $240/month. Injectable microdose, standard injectable, and oral RDT options have distinct pricing. Medication when approved, clinician consult and review, shipping, and injection supplies for injectable plans are included. Labs are separate when required.

Do I need labs before starting?

Not always. For GLP-1 weight loss, your clinician may start therapy from your intake alone, or order baseline metabolic markers first if your history calls for it. When labs are ordered, they’re drawn through a lab network near you — your clinician sends the order and you book a time. Panel pricing is confirmed before you’re charged.

Is compounded semaglutide the same as Ozempic or Wegovy?

No. Brand-name products such as Ozempic and Wegovy are FDA-approved medications with their own labeling and manufacturing pathway. Compounded formulations are prepared by state-licensed U.S. fulfillment facilities when a clinician prescribes them; their regulatory status differs from FDA-approved branded products. They should not be described as the same as, or equivalent to, brand-name pens.

Who should not take a GLP-1?

These medicines are not for use during pregnancy. If you become pregnant, contact your clinician and stop treatment as directed. If you are planning pregnancy, ask your clinician about timing (some labels advise stopping well before trying to conceive). If you are breastfeeding, discuss risks and benefits with your clinician before use — this is educational, not a diagnosis tool. Personal or family history of medullary thyroid carcinoma (MTC) or MEN2 are common label contraindications; a U.S.-licensed clinician decides eligibility after intake.

How do I know which GLP-1 fits me?

It depends on your goals, medical history, starting BMI, how you’ve tolerated medications before, and what you’re willing to spend monthly. The free 3-minute quiz organizes that context so a clinician can review what’s medically appropriate — including format and cost visibility before you continue.

Not sure which one fits you?

The 3-minute intake asks about your goal, history, and context, then helps route you toward the care path you may qualify for — including dose format and cost visibility before you continue. A licensed clinician reviews what’s medically appropriate next.

Take the free 3-minute quiz Explore the weight loss program

No card required · Clinician-reviewed · Prescribed only if medically appropriate · Available options confirmed by your assessment / state eligibility

Individual results vary. This guide is educational and is not medical advice.

Related guides

GLP-1 Weight Loss program How it works Ozempic vs Wegovy Tirzepatide cost